Mirum director granted RSUs and stock options
Mirum Pharmaceuticals director Lon Cardon received new equity awards as part of his compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Mirum Pharmaceuticals director Lon Cardon received new equity awards as part of his compensation. He was granted 1,980 restricted stock units, each representing the right to receive one share of common stock, and 3,772 stock options with an exercise price of $101.00 per share.
Both the RSUs and options vest on the first anniversary of the June 15, 2026 grant date, and in any event will be fully vested by the company’s 2027 annual stockholder meeting. After these awards, Cardon directly holds 1,980 RSUs and 3,772 options, with no shares bought or sold in this filing.
Insider Trade Summary
Grant/Award: 5,752 shares
Grant/Award
2 txns
Insider
Cardon Lon
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 3,772 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 1,980 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 3,772 contracts (Direct);
Restricted Stock Units — 1,980 contracts (Direct)
Footnotes (2)
- F1. The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting.
- F2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting.
Key Figures
RSU grant: 1,980 units
Option grant: 3,772 options
Option exercise price: $101.00 per share
+1 more
4 metrics
RSU grant
1,980 units
Restricted stock units granted June 15, 2026
Option grant
3,772 options
Stock options granted June 15, 2026
Option exercise price
$101.00 per share
Stock option strike price
Option expiration
June 14, 2036
Option expiration date
Key Terms
Restricted Stock Units, stock options, exercise price, vest, +1 more
5 terms
Restricted Stock Units financial
"He was granted 1,980 restricted stock units, each representing the right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock options financial
"and 3,772 stock options with an exercise price of $101.00 per share"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"3,772 stock options with an exercise price of $101.00 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"Both the RSUs and options vest on the first anniversary of the June 15, 2026 grant date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual stockholder meeting financial
"and in any event will be fully vested by the company’s 2027 annual stockholder meeting"
An annual stockholder meeting is a yearly gathering where a company's owners (shareholders) receive updates on performance, vote on key issues like board members, executive pay and major corporate plans, and ask questions of management. Think of it as a company town hall where choices about oversight and direction are decided; outcomes can affect management accountability, corporate strategy and ultimately the value and risks of investors’ shares.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Mirum Pharmaceuticals (MIRM) director Lon Cardon receive?
Lon Cardon received grants of RSUs and stock options. He was awarded 1,980 restricted stock units and 3,772 stock options, each tied to common shares, as part of his director compensation, with future vesting based on time and the 2027 annual meeting.
When do Lon Cardon’s new Mirum (MIRM) RSUs and options vest?
The RSUs and options primarily vest after one year. Both the 1,980 RSUs and 3,772 options vest on the first anniversary of the June 15, 2026 grant date, or will in any case be fully vested by Mirum’s 2027 annual stockholder meeting.
What is the exercise price of Lon Cardon’s Mirum (MIRM) stock options?
The granted stock options have a set exercise price. Cardon received 3,772 stock options with an exercise price of $101.00 per share, allowing him to purchase Mirum common stock at that price once the options vest and are exercisable.
How many Mirum (MIRM) awards does Lon Cardon hold after these grants?
The filing shows Cardon’s derivative holdings from these awards. After the June 15, 2026 grants, he directly holds 1,980 restricted stock units and 3,772 stock options, all tied to Mirum common shares, with vesting linked to time and the 2027 annual meeting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates